Xtant Medical makes bone graft materials and spinal implant systems for spine surgeons and hospitals. XTNT reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 2 | LUCID CAPITAL MARKETS | Initiated | Buy |
Seasonality
How XTNT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.
Whale Options Flow
90DNo whale options trades in XTNT in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XTNT is in one of them and how their past XTNT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered XTNT in an article yet. Here's the latest on the wider market.
About Xtant Medical Holdings
Xtant Medical makes orthobiologics, which are bone graft materials, along with spinal implant fixation systems used in spinal fusion surgery. Its products include human bone allografts, synthetic bone graft substitutes, and amniotic membrane allografts for wound care. Orthopedic spine surgeons and neurosurgeons are the main users, and the company sells mostly in the United States through independent agents and distributors, with some sales in Europe, Canada, Mexico, South America, and parts of the Pacific region. The company is based in Belgrade, Montana.
- Headquarters
- Belgrade, MT
- Founded
- 2006
- Website
- xtantmedical.com ↗